--- schema_version: "secwatch.filing_event.v1" accession: "0001171843-23-003310" form_type: "8-K" ticker: "HBIO" cik: "0001123494" company_name: "HARVARD BIOSCIENCE INC" filed_at: "2023-05-15T23:59:59+00:00" generated_at: "2026-06-15T00:36:30.298061+00:00" event_type: "other" sentiment: "neutral" materiality_score: 0.25 calibrated_materiality_score: 0.15 confidence: "high" source: SEC EDGAR --- # Harvard Bioscience shareholders re-elect directors, ratify auditor, approve say-on-pay at 2023 annual meeting ## Summary - Katherine A. Eade and Thomas W. Loewald re-elected as Class II directors with over 24.5M and 25.5M votes for, respectively. - Grant Thornton LLP ratified as independent auditor for FY2023 with 33.3M votes for, only 9,580 against. - Non-binding advisory vote on executive compensation approved (26.6M for vs 531,708 against). - Shareholders recommended a 1-year frequency for future say-on-pay votes (25.4M for 1 year); board adopted annual frequency. ## SEC filing metadata - accession: 0001171843-23-003310 - form_type: 8-K - ticker: HBIO - cik: 0001123494 - company_name: HARVARD BIOSCIENCE INC - filed_at: 2023-05-15T23:59:59+00:00 - event_type: other - sentiment: neutral - materiality_score: 0.25 - calibrated_materiality_score: 0.15 - confidence: high - sec_items: 5.07 - EDGAR index: https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/0001171843-23-003310-index.htm - EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/f8k_051523.htm ## Machine-readable alternates - HTML: https://secwatch.observer/filing/0001171843-23-003310 - JSON: https://secwatch.observer/filing/0001171843-23-003310.json - Plain text: https://secwatch.observer/filing/0001171843-23-003310.txt ## Key facts - Shareholder Votes HARVARD BIOSCIENCE INC shareholders voted on Recommendation, by Non-Binding Advisory Vote, of the Frequency (One, Two or Three Years) of the Shareholder Vote on the Compensation of the Named Executive Officers at the 2023-05-15 meeting. - Proposal: say on pay frequency - Meeting: 2023-05-15 source text: Proposal 4 –Recommendation, by Non-Binding Advisory Vote, of the Frequency (One, Two or Three Years), of the Shareholder Vote on the Compensation of the Named Executive Officers The Company’s stockholders recommended a frequency of one year for the stockholder vote on the compensation of the Company’s named executive officers, by a non-binding advisory vote: Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained Broker Non-Votes 25,372,472 24,073 1,498,941 240,001 6,260,898 evidence_url: https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/0001171843-23-003310-index.htm - Shareholder Votes HARVARD BIOSCIENCE INC shareholders approved Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers at the 2023-05-15 meeting. - Proposal: say on pay - Outcome: passed - Meeting: 2023-05-15 source text: Proposal 3 –Approval, by Non-Binding Advisory Vote, of the Compensation of the Named Executive Officers The Company’s stockholders approved the compensation of the Company’s named executive officers, by a non-binding advisory vote: Votes For Votes Against Votes Abstained Broker Non-Votes 26,568,836 531,708 34,943 6,260,898 evidence_url: https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/0001171843-23-003310-index.htm - Shareholder Votes HARVARD BIOSCIENCE INC shareholders approved Election of Class II Directors for a three-year term at the 2023-05-15 meeting. - Proposal: director election - Outcome: passed - Meeting: 2023-05-15 source text: Proposal 1 - Election of Directors The Company’s stockholders elected two Class II Directors for a three-year term, such term to continue until the annual meeting of stockholders in 2026 and until such director’s successor is duly elected and qualified or until his or her earlier resignation or removal. Name Votes For Votes Withheld Broker Non-Votes Katherine A. Eade 24,519,192 2,616,295 6,260,898 Thomas W. Loewald 25,564,902 1,570,585 6,260,898 evidence_url: https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/0001171843-23-003310-index.htm - Shareholder Votes HARVARD BIOSCIENCE INC shareholders approved Ratification of the Appointment of Grant Thornton LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-05-15 meeting. - Proposal: auditor ratification - Outcome: passed - Meeting: 2023-05-15 source text: Proposal 2 –Ratification of the Appointment of Grant Thornton LLP The Company’s stockholders ratified the appointment of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. There were no broker non-votes on this proposal. Votes For Votes Against Votes Abstained 33,325,418 9,580 61,387 evidence_url: https://www.sec.gov/Archives/edgar/data/1123494/000117184323003310/0001171843-23-003310-index.htm This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.